Klingenstein Fields & CO LP Merck & Co., Inc. Transaction History

Klingenstein Fields & CO LP

$2.48 Billion
Q3 2024

A detailed history of Klingenstein Fields & CO LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 279,198 shares of MRK stock, worth $27.2 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares

279,198

Previous 284,878 1.99%

Holding current value

$27.2 Million

Previous $35.3 Million 10.1%

% of portfolio

1.28%

Previous 1.48%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$111.15 - $128.97 $631,332 - $732,549	-5,680 Reduced 1.99%	279,198 $31.7 Million
Q2 2024 Aug 01, 2024	SELL	$123.8 - $132.96 $2.43 Million - $2.61 Million	-19,597 Reduced 6.44%	284,878 $35.3 Million
Q1 2024 Apr 29, 2024	SELL	$113.24 - $131.95 $956,198 - $1.11 Million	-8,444 Reduced 2.7%	304,475 $40.2 Million
Q4 2023 Feb 01, 2024	SELL	$100.18 - $109.02 $246,142 - $267,862	-2,457 Reduced 0.78%	312,919 $34.1 Million
Q3 2023 Oct 27, 2023	SELL	$102.95 - $114.33 $63,623 - $70,655	-618 Reduced 0.2%	315,376 $32.5 Million
Q2 2023 Aug 01, 2023	SELL	$108.61 - $118.38 $400,119 - $436,111	-3,684 Reduced 1.15%	315,994 $36.5 Million
Q1 2023 Apr 28, 2023	SELL	$102.94 - $114.86 $398,789 - $444,967	-3,874 Reduced 1.2%	319,678 $34 Million
Q4 2022 Feb 02, 2023	SELL	$87.44 - $112.11 $673,462 - $863,471	-7,702 Reduced 2.33%	323,552 $35.9 Million
Q3 2022 Oct 28, 2022	BUY	$84.53 - $94.96 $18,765 - $21,081	222 Added 0.07%	331,254 $28.5 Million
Q2 2022 Aug 01, 2022	BUY	$83.49 - $94.64 $2,838 - $3,217	34 Added 0.01%	331,032 $30.2 Million
Q1 2022 Apr 27, 2022	BUY	$73.51 - $82.4 $172,160 - $192,980	2,342 Added 0.71%	330,998 $27.2 Million
Q4 2021 Jan 31, 2022	SELL	$72.28 - $90.54 $409,538 - $512,999	-5,666 Reduced 1.69%	328,656 $25.2 Million
Q3 2021 Oct 26, 2021	BUY	$71.68 - $78.83 $41,574 - $45,721	580 Added 0.17%	334,322 $25.1 Million
Q2 2021 Jul 26, 2021	BUY	$70.31 - $77.77 $226,046 - $250,030	3,215 Added 0.97%	333,742 $26 Million
Q1 2021 Apr 29, 2021	BUY	$68.86 - $81.11 $135,791 - $159,948	1,972 Added 0.6%	330,527 $25.5 Million
Q4 2020 Feb 02, 2021	BUY	$71.77 - $79.65 $86,913 - $96,456	1,211 Added 0.37%	328,555 $26.9 Million
Q3 2020 Oct 30, 2020	SELL	$73.18 - $82.95 $185,584 - $210,361	-2,536 Reduced 0.77%	327,344 $27.2 Million
Q2 2020 Aug 03, 2020	SELL	$70.42 - $80.13 $62,251 - $70,834	-884 Reduced 0.27%	329,880 $25.5 Million
Q1 2020 May 07, 2020	SELL	$63.36 - $87.82 $35,228 - $48,827	-556 Reduced 0.17%	330,764 $25.4 Million
Q4 2019 Feb 04, 2020	SELL	$77.58 - $87.54 $563,696 - $636,065	-7,266 Reduced 2.15%	331,320 $30.1 Million
Q3 2019 Nov 01, 2019	SELL	$76.08 - $82.93 $413,646 - $450,890	-5,437 Reduced 1.58%	338,586 $28.5 Million
Q2 2019 Aug 12, 2019	SELL	$69.84 - $81.59 $621,576 - $726,151	-8,900 Reduced 2.52%	344,023 $28.8 Million
Q1 2019 Apr 29, 2019	SELL	$69.58 - $79.36 $7.76 Million - $8.85 Million	-111,500 Reduced 24.01%	352,923 $29.4 Million
Q4 2018 Jan 22, 2019	SELL	$65.24 - $75.71 $771,267 - $895,043	-11,822 Reduced 2.48%	464,423 $35.5 Million
Q3 2018 Nov 01, 2018	BUY	$57.69 - $67.84 $909,482 - $1.07 Million	15,765 Added 3.42%	476,245 $33.8 Million
Q2 2018 Jul 26, 2018	BUY	$50.83 - $59.72 $781,917 - $918,672	15,383 Added 3.46%	460,480 $28 Million
Q1 2018 May 01, 2018	BUY	$50.96 - $59.23 $32,920 - $38,262	646 Added 0.15%	445,097 $24.2 Million
Q4 2017 Jan 30, 2018	BUY	$51.62 - $61.64 $130,598 - $155,949	2,530 Added 0.57%	444,451 $25 Million
Q3 2017 Nov 01, 2017	BUY	$58.67 - $63.13 $25.9 Million - $27.9 Million	441,921	441,921 $28.3 Million

Others Institutions Holding MRK

# of Institutions

3,819

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.

Account

Klingenstein Fields & CO LP Merck & Co., Inc. Transaction History